Of individuals with lethal OI due to splice site mutations, more than 50% carry variants in COL1A2 (7 of 53, 13.2%) as compared with COL1A1 variants (11 of 216, 5%). This evidence concerns the gene COL1A1 and osteogenesis imperfecta.